参考文献/References:
[1]Sung H,Ferlay J,Siegel RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin,2021,71(3):209-249.
[2]Zhang J,Li X,Lin J,et al.Modified cancer TNM classification for localized renal cell carcinoma based on the prognostic analysis of 3748 cases from a single center.Can J Physiol Pharmacol,2022,100(1):5-11.
[3]郎景和.肿瘤—手术—微创.中国微创外科杂志,2023,23(1):1-2.
[4]洪保安,杜鑫,纪永鹏,等.经腹腔镜微波消融联合肾部分切除术治疗肾肿瘤的安全性和疗效.中华医学杂志,2021,101(46):3794-3798.
[5]Yu J,Yu XL,Cheng ZG,et al.Percutaneous microwave ablation of renal cell carcinoma:practice guidelines of the Ultrasound Committee of Chinese Medical Association,Interventional Oncology Committee of Chinese Research Hospital Association.Int J Hyperthermia,2020,37(1):827-835.
[6]Yoo S,You D,Jeong IG,et al.Preserving renal function through partial nephrectomy depends on tumor complexity in T1b renal tumors.J Korean Med Sci,2017,32(3):495-501.
[7]Sharafeldeen M,Sameh W,Mehrnoush V,et al.Partial nephrectomy for T1b/T2 renal mass:an added shift from radical nephrectomy.J Kidney Cancer VHL,2022,9(4):1-5.
[8]Cai Y,Li HZ,Zhang YS.Comparison of partial and radical laparascopic nephrectomy: longterm outcomes for clinical T1b renal cell carcinoma.Urol J,2018,15(2):16-20.
[9]Mir MC,Derweesh I,Porpiglia F,et al.Partial nephrectomy versus radical nephrectomy for clinical T1b and T2 renal tumors: a systematic review and metaanalysis of comparative studies.Eur Urol,2017,71(4):606-617.
[10]Yang F,Zhou Q,Xing N.Comparison of survival and renal function between partial and radical laparoscopic nephrectomy for T1b renal cell carcinoma.J Cancer Res Clin Oncol,2020,146(1):261-272.
[11]Liu G,Ma Y,Wang S,et al.Laparoscopic versus open radical nephrectomy for renal cell carcinoma:a systematic review and metaanalysis.Transl Oncol,2017,10(4):501-510.
[12]Dursun F,Elshabrawy A,Wang H,et al.Survival after minimally invasive vs. open radical nephrectomy for stage I and II renal cell carcinoma.Int J Clin Oncol,2022,27(6):1068-1076.
[13]Golombos DM,Chughtai B,Trinh QD,et al.Minimally invasive vs open nephrectomy in the modern era: does approach matter?World J Urol,2017,35(10):1557-1568.
[14]Wang L,Li KP,Yin S,et al.Oncologic and perioperative outcomes of laparoscopic versus open radical nephrectomy for the treatment of renal tumor (> 7 cm):a systematic review and pooled analysis of comparative outcomes.World J Surg Oncol,2023,21(1):35.
[15]Campbell S,Uzzo RG,Allaf ME,et al.Renal mass and localized renal cancer:AUA guideline.J Urol,2017,198(3):520-529.
[16]Lai GS,Hung SC,Chang LW,et al.Renal volume matters:assessing the association between excisional volume loss and renal function after partial nephrectomy.Asian J Surg,2020,43(1):257-264.
[17]Ljungberg B,Albiges L,AbuGhanem Y,et al.European Association of Urology guidelines on renal cell carcinoma:the 2022 update.Eur Urol,2022,82(4):399-410.
[18]Qian J,Li P,Qin C,et al.Laparoscopic partial nephrectomy with precise segmental renal artery clamping for clinical T1b tumors.J Endourol,2015,29(12):1386-1391.
[19]Lee H,Oh JJ,Byun SS,et al.Can partial nephrectomy provide equal oncological efficiency and safety compared with radical nephrectomy in patients with renal cell carcinoma (>/=4cm)?A propensity scorematched study.Urol Oncol,2017,35(6):379-385.
[20]张乐飞,易发现.肾部分切除术的研究进展.中国微创外科杂志,2020,20(2):164-167.
[21]陆旭伟,王杭,郭锥锋,等.后腹腔镜下保留肾单位手术在T1b期肾肿瘤切除中的应用.中华医学杂志,2018,98(38):3084-3086.
[22]Campbell RA,Scovell J,Rathi N,et al.Partial versus radical nephrectomy: complexity of decisionmaking and utility of AUA guidelines.Clin Genitourin Cancer,2022,20(6):501-509.
[23]Shibamori K,Hashimoto K,Shindo T,et al.Outcomes of open partial nephrectomy for renal cell carcinoma in the minimally invasive approach era.Curr Urol,2021,15(4):198-203.
[24]Liu Z,Zhang X,Lv P,et al.Functional,oncological outcomes and safety of laparoscopic partial nephrectomy versus open partial nephrectomy in localized renal cell carcinoma patients with high anatomical complexity.Surg Endosc,2022,36(10):7629-7637.
[25]Veys R,Abdollah F,Briganti A,et al.Oncological and functional efficacy of nephronsparing surgery versus radical nephrectomy in renal cell carcinoma stages >/=cT1b:a single institution,matched analysis.Cent European J Urol,2018,71(1):48-57.
[26]Jiang YL,Peng CX,Wang HZ,et al.Comparison of the longterm followup and perioperative outcomes of partial nephrectomy and radical nephrectomy for 4 cm to 7 cm renal cell carcinoma:a systematic review and metaanalysis.BMC Urol,2019,19(1):48.
[27]姜伟,张胜捷,李笑弓.射频消融治疗肾细胞癌的研究进展.东南大学学报(医学版),2016,35(5):785-788.
[28]Chan VW,Abul A,Osman FH,et al.Ablative therapies versus partial nephrectomy for small renal masses:a systematic review and metaanalysis.Int J Surg,2022,97:106194.
[29]Rembeyo G,Correas JM,Jantzen R,et al.Percutaneous ablation versus robotic partial nephrectomy in the treatment of cT1b renal tumors:oncologic and functional outcomes of a propensity scoreweighted analysis.Clin Genitourin Cancer,2020,18(2):138-147.
[30]Cazalas G,Jambon E,Coussy A,et al.Local recurrence and other oncologic outcomes after percutaneous imageguided tumor ablations on stage T1b renal cell carcinoma:a systematic review and network metaanalysis.Int J Hyperthermia,2021,38(1):1295-1303.
[31]Zhang F,Chang X,Liu T,et al.Prognostic factors for longterm survival in patients with renalcell carcinoma after radiofrequency ablation.J Endourol,2016,30(1):37-42.
[32]Liu N,Huang D,Cheng X,et al.Percutaneous radiofrequency ablation for renal cell carcinoma vs. partial nephrectomy:comparison of longterm oncologic outcomes in both clear cell and nonclear cell of the most common subtype.Urol Oncol,2017,35(8):530 e1-e6.
[33]Atwell TD,Vlaminck JJ,Boorjian SA,et al.Percutaneous cryoablation of stage T1b renal cell carcinoma:technique considerations,safety,and local tumor control.J Vasc Interv Radiol,2015,26(6):792-799.
[34]莫承强,蒋双键,李柏谋,等.超声引导下射频消融治疗小肾癌32例疗效分析.现代泌尿外科杂志,2017,22(10):743-747.
[35]Song S,Yang Q,Gu C,et al.Longterm outcomes of cryoablation for biopsyproven T1 stage renal cell carcinoma. World J Surg Oncol,2022,20(1):284.
[36]Shimizu K,Enoki K,Kameoka Y,et al. Imageguided percutaneous cryoablation of T1b renal cell carcinomas in patients with comorbidities.Jpn J Radiol,2021,39(12):1213-1222.
[37]张肖,肖越勇,李成利.影像学引导肾癌冷冻消融专家共识2019版.中国介入影像与治疗学,2019,16(2):65-70.
[38]Yanagisawa T,Miki J,Shimizu K,et al.Functional and oncological outcome of percutaneous cryoablation versus laparoscopic partial nephrectomy for clinical T1 renal tumors:a propensity scorematched analysis.Urol Oncol,2020,38(12):938 e1-e7.
[39]Deng W,Chen L,Wang Y,et al.Cryoablation versus partial nephrectomy for clinical stage T1 renal masses:a systematic review and metaanalysis.J Cancer,2019,10(5):1226-1236.
[40]Spiliopoulos S,Marzoug A,Ra H,et al.Longterm outcomes of CTguided percutaneous cryoablation of T1a and T1b renal cell carcinoma.Diagn Interv Radiol,2021,27(4):524-528.
[41]Pecoraro A,Palumbo C,Knipper S,et al.Cryoablation predisposes to higher cancer specific mortality relative to partial nephrectomy in patients with nonmetastatic pT1b kidney cancer.J Urol,2019,202(6):1120-1126.
[42]Gunn AJ,Joe WB,Salei A,et al.Percutaneous cryoablation of stage T1b renal cell carcinoma:safety,technical results,and clinical outcomes.Cardiovasc Intervent Radiol,2019,42(7):970-978.
[43]Sui G,Luo Q,Du J,et al.Clinical application of ultrasoundguided percutaneous microwave ablation in the treatment of T1aN0M0 stage renal carcinoma.J Med Ultrason(2001),2019,46(2):217-222.
[44]洪保安,张小东,邢念增,等.微波消融治疗肾癌的研究进展.临床泌尿外科杂志,2014,29(5):448-451.
[45]Guo J,Arellano RS.Percutaneous microwave ablation of stage T1b renal cell carcinoma:shortterm assessment of technical feasibility,shortterm oncologic outcomes,and safety.J Endourol,2020,34(10):1021-1027.
[46]Krieger JR,Lee FT Jr,Mccormick T,et al.Microwave ablation of renal cell carcinoma.J Endourol,2021,35(S2):33-37.
[47]Shapiro DD,Wells SA,Best SL,et al.Comparing outcomes for patients with clinical T1b renal cell carcinoma treated with either percutaneous microwave ablation or surgery.Urology,2020,135:88-94.
[48]Wetley KA,Abel EJ,Dreyfuss LD,et al.CT and MR imaging surveillance of stage 1 renal cell carcinoma after microwave ablation. Abdom Radiol (NY),2020,45(9):2810-2824.
[49]Dreyfuss LD,Wells SA,Best SL,et al.Development of a riskstratified approach for followup imaging after percutaneous thermal ablation of sporadic stage one renal cell carcinoma.Urology,2019,134:148-153.